When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Saccharomyces boulardii - Wikipedia

   en.wikipedia.org/wiki/Saccharomyces_boulardii

   Saccharomyces boulardii is a tropical yeast first isolated from lychee and mangosteen peels in 1923 by French scientist Henri Boulard. Although early reports claimed distinct taxonomic , metabolic, and genetic properties, [ 1 ] S. boulardii is a grouping of S. cerevisiae strains, all sharing a >99% genomic relatedness.

3. Modified-release dosage - Wikipedia

   en.wikipedia.org/wiki/Modified-release_dosage

   Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage). [1]

4. Henri Boulard - Wikipedia

   en.wikipedia.org/wiki/Henri_Boulard

   Henri Boulard was a French microbiologist who discovered the yeast Saccharomyces boulardii in 1923. He noticed people chewing on the skins of lychees and mangosteens to treat diarrhea during a cholera epidemic. He isolated and identified this strain of yeast, a probiotic. [1]

5. Fed-batch culture - Wikipedia

   en.wikipedia.org/wiki/Fed-batch_culture

   Fed-batch reactor symbol. Fed-batch culture is, in the broadest sense, defined as an operational technique in biotechnological processes where one or more nutrients (substrates) are fed (supplied) to the bioreactor during cultivation and in which the product(s) remain in the bioreactor until the end of the run. [1]

6. Budesonide - Wikipedia

   en.wikipedia.org/wiki/Budesonide

   Formulations of delayed-release budesonide are an effective treatment for mild-to-moderately active Crohn's disease involving the ileum and/or ascending colon. [25] A Cochrane review found evidence for up to three months (but not longer) of maintenance of remission in Crohn's disease, concluding that budesonide is not effective for maintenance of remission in CD.

7. Cycloheximide - Wikipedia

   en.wikipedia.org/wiki/Cycloheximide

   Candida albicans: 12.5 μg/ml; Mycosphaerella graminicola: 47.2 μg/ml – 85.4 μg/ml; Saccharomyces cerevisiae: 0.05 μg/ml – 1.6 μg/ml; Neoscytalidium dimidiatum is an Athlete's foot like infection resistant to most antifungals but is rather sensitive to cycloheximide, so, it should be cultured in a medium free of cycloheximide.